In vitro potency and efficacy favor later generation fluoroquinolones for treatment of canine and feline Escherichia coli uropathogens in the United States.

@article{Liu2013InVP,
  title={In vitro potency and efficacy favor later generation fluoroquinolones for treatment of canine and feline Escherichia coli uropathogens in the United States.},
  author={Xiaoqiang Liu and Dawn Merton Boothe and Yaping Jin and Kamoltip Thungrat},
  journal={World journal of microbiology & biotechnology},
  year={2013},
  volume={29 2},
  pages={
          347-54
        }
}
Information regarding in vitro activity of newer fluoroquinolones (FQs) is limited despite increasing resistance in canine or feline pathogenic Escherichia coli (E. coli). This study describes in vitro potency and efficacy toward E. coli of seven FQs grouped according to similarities in chemical structure: enrofloxacin, ciprofloxacin, orbifloxacin (first-group), levofloxacin, marbofloxacin (second-group) and pradofloxacin, moxifloxacin (third-group; latest S, S-pyrrolidino-piperidine at C-7… CONTINUE READING
BETA

References

Publications referenced by this paper.
SHOWING 1-10 OF 23 REFERENCES

Similar Papers

Loading similar papers…